{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T15:11:09Z","timestamp":1782659469710,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bcmd.2015.12.005","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T09:59:18Z","timestamp":1450173558000},"page":"54-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients"],"prefix":"10.1016","volume":"57","author":[{"given":"Luciana Conci","family":"Macedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"de Cesare Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pagliari-E-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia Borgia Barbosa","family":"Pagnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane Bazzo","family":"de Alencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Sell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeane Eliete Laguila","family":"Visentainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2015.12.005_bb0005","series-title":"Evolu\u00e7\u00e3o da Biologia Molecular nos S\u00edndromes Mieloproliferativos Cr\u00f4nicos e Aplica\u00e7\u00e3o do seu Diagn\u00f3stico na Atualidade","author":"Rua","year":"2011"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2004.02.002","article-title":"Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders","volume":"19","author":"Kralovics","year":"2005","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0015","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2009.149","article-title":"Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics","volume":"6","author":"Tefferi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.bcmd.2015.12.005_bb0025","doi-asserted-by":"crossref","first-page":"16651","DOI":"10.1074\/jbc.M109.071191","article-title":"Activation of JAK2-V617F by components of heterodimeric cytokine receptors","volume":"285","author":"Pradhan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0030","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1038\/sj.onc.1210757","article-title":"Hematopoietic cytokine receptor signaling","volume":"26","author":"Baker","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0035","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1200\/JCO.2004.00.9316","article-title":"Pathogenesis of myelofibrosis with myeloid metaplasia","volume":"23","author":"Tefferi","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-0609.2012.01836.x","article-title":"Polymorphisms of tumor necrosis factor gene in primary myelofibrosis","volume":"89","author":"Liu","year":"2012","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcmd.2015.12.005_bb0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2014.01.006","article-title":"Cytokine profiles in polycythemia vera and essential thrombocythemia patients: clinical implications","volume":"42","author":"Pourcelot","year":"2014","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0055","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V91.10.3574","article-title":"Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome","volume":"91","author":"Warzocha","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2141.1997.9912636.x","article-title":"Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia","volume":"97","author":"Demeter","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0065","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V100.6.2263","article-title":"Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for out come after thalidomide therapy in relapsed and refractory multiple myeloma","volume":"100","author":"Neben","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5301\/JBM.2011.8580","article-title":"Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case\u2013control study in a Han Chinese population","volume":"26","author":"Chen","year":"2011","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2005\/707131","article-title":"TNF-a, TNF-\u03b2, IL-6, and IL-10 polymorphisms in patients with lung cancer","volume":"21","author":"Seifart","year":"2005","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lungcan.2005.11.011","article-title":"Association of TNF-a polymorphism with susceptibility to and severity of non-small cell lung cancer","volume":"52","author":"Shih","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0085","first-page":"846","article-title":"TNF-a gene polymorphisms in lung cancer as a second primary tumor","volume":"19","author":"Flego","year":"2013","journal-title":"Clin. Med. Sci."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.005_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/S1516-84842008000300014","article-title":"A mutac\u00e3o JAK2 V617F e as s\u00edndromes mieloproliferativas","volume":"30","author":"Monte-Mor","year":"2008","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"2","key":"10.1016\/j.bcmd.2015.12.005_bb0095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/S1415-47572007000300006","article-title":"JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia","volume":"30","author":"Monte-Mor","year":"2007","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000264954","article-title":"Development of a reliable PCR-RFLP assay for investigation of the JAK2 rs10974944 SNP, which might predispose to the acquisition of somatic mutation JAK2 V617F","volume":"123","author":"Trifa","year":"2010","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.6061\/clinics\/2013(01)OA02","article-title":"Evaluation of the association between the JAK2 46\/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population","volume":"68","author":"Pagliarini-e-Silva","year":"2013","journal-title":"Clinics"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00001432-200306000-00002","article-title":"Host innate defenses in the lung: the role of cytokines","volume":"16","author":"Strieter","year":"2003","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00251-005-0800-8","article-title":"Identification of regulatory polymorphisms in the TNF\u2013TNF receptor superfamily","volume":"57","author":"Kim","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/cyto.1999.0529","article-title":"Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism","volume":"12","author":"Kroeger","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0130","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1046\/j.1523-1747.2000.00001.x","article-title":"Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism","volume":"114","author":"Kaluza","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3835(01)00438-4","article-title":"The -238 tumor necrosis factor-alpha promoter polymorphisms associated with decreased susceptibility to cancers","volume":"166","author":"Jang","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/rheumatology\/36.5.516","article-title":"Tumour necrosis factor alpha gene polymorphismsin rheumatoid arthritis: association with susceptibility to, or severity of, disease?","volume":"36","author":"Brinkman","year":"2007","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2","article-title":"Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection","volume":"54","author":"Hohler","year":"1998","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0150","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1489::AID-CNCR17>3.0.CO;2-1","article-title":"Polymorphismin the tumor necrosis factor-alpha promoter region and in the heat shock protein 70 genes associated with malignant tumors","volume":"80","author":"Chouchane","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2015.12.005_bb0155","first-page":"369","article-title":"Frequent genotype changes at -308 of the human tumor necrosis factor-alpha promoter region in human uterine endometrial cancer","volume":"7","author":"Sasaki","year":"2000","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0160","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK\u2013STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semcdb.2008.08.010","article-title":"Interferons pen the JAK\u2013STAT pathway","volume":"19","author":"Schindler","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bcmd.2015.12.005_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/exd.12265","article-title":"JAKpot! New small molecules in autoimmune and inflammatory diseases","volume":"23","author":"Ghoreschi","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bcmd.2015.12.005_bb0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cytogfr.2013.01.004","article-title":"The role of cytokines in the initiation and progression of myelofibrosis","volume":"24","author":"Hasselbalch","year":"2013","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615300206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615300206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:32:00Z","timestamp":1761049920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979615300206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"alternative-id":["S1079979615300206"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.12.005","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}